Assura logo

AGR - Assura Share Price

80.7p -0.3  -0.4%

Last Trade - 05/06/20

Mid Cap
Market Cap £2.15bn
Enterprise Value £2.98bn
Revenue £111.5m
Position in Universe 259th / 1817
Unlock AGR Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, Assura PLC revenues increased 9% to £111.5M. Net income decreased 6% to £78.9M. Revenues reflect Gross rental and related income increase of 9% to £107.8M, Other related income increase of 19% to £3.7M. Net income was offset by Revaluation gains decrease of 52% to £9.7M (income), Interest payable increase of 17% to £25.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


AGR Revenue Unlock AGR Revenue

Net Income

AGR Net Income Unlock AGR Revenue

Normalised EPS

AGR Normalised EPS Unlock AGR Revenue

PE Ratio Range

AGR PE Ratio Range Unlock AGR Revenue

Dividend Yield Range

AGR Dividend Yield Range Unlock AGR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AGR EPS Forecasts Unlock AGR Revenue
Profile Summary

Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company's property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston. The Company's subsidiaries include Abbey Healthcare Group Ltd, Abbey Healthcare Property Investments Ltd, Assura Aspire Ltd, Assura Aspire UK Ltd, Assura HC UK Ltd, Assura Primary Care Properties Ltd and Assura Trellech Ltd.

Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated December 10, 2014
Public Since January 28, 2015
No. of Shareholders: n/a
No. of Employees: 73
Sector Financials
Industry Residential & Commercial REITs
Index FTSE All Share , FTSE All Share Financials , FTSE 350 Higher Yield , FTSE 350 , FTSE 250 , FTSE 350 Real Estate Investment Trusts, FT350 Real Estat , ,
Exchange London Stock Exchange (Full)
Shares in Issue 2,659,993,187
Free Float (0.0%)
Eligible for
AGR Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for AGR
Upcoming Events for AGR
Thursday 11th June, 2020
Dividend For AGRP.L - 0.7100 GBX
Wednesday 1st July, 2020 Estimate
Assura PLC Annual Shareholders Meeting
Tuesday 7th July, 2020
Assura PLC Annual Shareholders Meeting
Tuesday 10th November, 2020 Estimate
Half Year 2021 Assura PLC Earnings Release
Frequently Asked Questions for Assura
What is the Assura share price?

As of 05/06/20, shares in Assura are trading at 80.7p, giving the company a market capitalisation of £2.15bn. This share price information is delayed by 15 minutes.

How has the Assura share price performed this year?

Shares in Assura are currently trading at 80.7p and the price has moved by 26.29% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Assura price has moved by 44.22% over the past year.

What are the analyst and broker recommendations for Assura?

Of the analysts with advisory recommendations for Assura, there are there are currently 2 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Assura is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Assura next release its financial results?

Assura is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Assura dividend yield?

Assura does not currently pay a dividend.

Does Assura pay a dividend?

Assura does not currently pay a dividend.

When does Assura next pay dividends?

Assura does not currently pay a dividend.

How do I buy Assura shares?

To buy shares in Assura you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Assura?

Shares in Assura are currently trading at 80.7p, giving the company a market capitalisation of £2.15bn.

Where are Assura shares listed? Where are Assura shares listed?

Here are the trading details for Assura:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: AGR
What kind of share is Assura?

Based on an overall assessment of its quality, value and momentum, Assura is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Assura share price forecast 2020?

Shares in Assura are currently priced at 80.7p. At that level they are trading at 4.09% discount to the analyst consensus target price of 84.14.

Analysts covering Assura currently have a consensus Earnings Per Share (EPS) forecast of 0.02817 for the next financial year.

How can I tell whether the Assura share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Assura. Over the past six months, the relative strength of its shares against the market has been 18.5%. At the current price of 80.7p, shares in Assura are trading at 7.02% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Assura PE Ratio?

The Assura PE ratio based on its reported earnings over the past 12 months is 24.65. The shares are currently trading at 80.7p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Assura?

Assura's management team is headed by:

Jonathan Murphy - CEO
Jayne Cottam - CFO
Orla Ball - SEC
Ed Smith - NEC
Jonathan Davies - NID
Jenefer Greenwood - NID
Louise Fowler - NID
Who are the major shareholders of Assura?

Here are the top five shareholders of Assura based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 9.03% (240.3m shares)
Artemis Investment Management LLP Investment Advisor/Hedge Fund
Percentage owned: 7.78% (206.9m shares)
Aberdeen Asset Managers Ltd. Investment Advisor/Hedge Fund
Percentage owned: 5.39% (143.3m shares)
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund
Percentage owned: 4.95% (131.5m shares)
Resolution Capital Limited Investment Advisor
Percentage owned: 4.69% (124.7m shares)
Similar to AGR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.